Report overview
Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone) is a combination of two antibiotics and a steroid used to treat bacterial infections of the eyes. Ophthalmic Suspension is available in generic form.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Suspension, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Suspension. This report contains market size and forecasts of Ophthalmic Suspension in global, including the following market information:
Global Ophthalmic Suspension Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ophthalmic Suspension Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ophthalmic Suspension companies in 2022 (%)
The global Ophthalmic Suspension market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increasing prevalence of eye diseases across the globe is one of the major factors contributing to the growth of this market. Moreover, increasing geriatric population which are most prone to eye disorders, and growing number of bacterial infections cases in children will also boost the growth of the market. Furthermore, according to WHO (2014), glaucoma is the second major cause of blindness in the world which will increase the market growth.
We surveyed the Ophthalmic Suspension manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Suspension Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Suspension Market Segment Percentages, by Type, 2022 (%)
Antibiotic
Antifungal
Antibacterial
Steroids
NSAIDs
Others
Global Ophthalmic Suspension Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Suspension Market Segment Percentages, by Application, 2022 (%)
Hospital
Eye Clinic
Others
Global Ophthalmic Suspension Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Suspension Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Suspension revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ophthalmic Suspension revenues share in global market, 2022 (%)
Key companies Ophthalmic Suspension sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ophthalmic Suspension sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Merck
Novartis
Bausch & Lomb
Falcon Group
Pfizer
Valeant
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Suspension, market overview.
Chapter 2: Global Ophthalmic Suspension market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Suspension manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Suspension in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Suspension capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
